Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Ardito

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|June 11, 2025
Exosomes and immune modulation: implications for neuroblastoma immunotherapyMartina Morini, Chiara Vitale, Martina Ardito, et al.
Journal of the Mechanical Behavior of Biomedical Materials|June 1, 2019
Biomechanics of cultured hepatic cells during different steatogenic hitsFrancesca Baldini, Alice Bartolozzi, Martina Ardito, et al.
Cells|November 10, 2023
Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma PatientsMartina Morini, Federica Raggi, Martina Bartolucci, et al.
Cells|June 11, 2026
Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma ModelsVeronica Bensa, Hugo Lopes-Cardoso, Martina Ardito, et al.
HLA|May 15, 2024
Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencingFerdinando Bonfiglio, Vito Alessandro Lasorsa, Vincenzo Aievola, et al.
The Oncologist|February 13, 2025
Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluationMartina Morini, Sebastiano Barco, Martina Ardito, et al.
Ebiomedicine|December 9, 2022
Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastomaFerdinando Bonfiglio, Vito Alessandro Lasorsa, Sueva Cantalupo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2025
The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid MetabolismTeresa Maiorino, Marianna Avitabile, Vincenzo Aievola, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 23, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugsVeronica Bensa, Hugo Lopes-Cardoso, Eleonora Ciampi, et al.
JCO Precision Oncology|July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyHannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|June 11, 2025
Exosomes and immune modulation: implications for neuroblastoma immunotherapyMartina Morini, Chiara Vitale, Martina Ardito, et al.
Journal of the Mechanical Behavior of Biomedical Materials|June 1, 2019
Biomechanics of cultured hepatic cells during different steatogenic hitsFrancesca Baldini, Alice Bartolozzi, Martina Ardito, et al.
Cells|November 10, 2023
Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma PatientsMartina Morini, Federica Raggi, Martina Bartolucci, et al.
Cells|June 11, 2026
Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma ModelsVeronica Bensa, Hugo Lopes-Cardoso, Martina Ardito, et al.
HLA|May 15, 2024
Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencingFerdinando Bonfiglio, Vito Alessandro Lasorsa, Vincenzo Aievola, et al.
The Oncologist|February 13, 2025
Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluationMartina Morini, Sebastiano Barco, Martina Ardito, et al.
Ebiomedicine|December 9, 2022
Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastomaFerdinando Bonfiglio, Vito Alessandro Lasorsa, Sueva Cantalupo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2025
The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid MetabolismTeresa Maiorino, Marianna Avitabile, Vincenzo Aievola, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 23, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugsVeronica Bensa, Hugo Lopes-Cardoso, Eleonora Ciampi, et al.
JCO Precision Oncology|July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyHannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
Pageof 1